Results 171 to 180 of about 47,712 (207)
Some of the next articles are maybe not open access.
Neoadjuvant GLP-1 Receptor Agonists in Sleep Surgery
JAMA Otolaryngology–Head & Neck SurgeryThis Viewpoint examines the potential role of neoadjuvant and adjuvant glucagon-like peptide–1 (GLP-1) receptor agonist therapy in improving surgical outcomes for patients with obstructive sleep apnea and obesity.
Ryan Chin Taw, Cheong, Kenny Peter, Pang
openaire +2 more sources
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Frontiers in Endocrinology, 2021Lijuan Cui, Yunfeng Liu, Yi Zhang
exaly
Medicina Clínica (English Edition)
Obesity represents a global public health challenge, with specific characteristics and needs in adolescent and elderly populations. GLP-1 (glucagon-like peptide-1) receptor agonists such as liraglutide and semaglutide, as well as the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor co-agonist tirzepatide, have emerged as promising ...
openaire +2 more sources
Obesity represents a global public health challenge, with specific characteristics and needs in adolescent and elderly populations. GLP-1 (glucagon-like peptide-1) receptor agonists such as liraglutide and semaglutide, as well as the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor co-agonist tirzepatide, have emerged as promising ...
openaire +2 more sources
GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
New England Journal of Medicine, 2023Sean, Wharton, Manige, Konig
openaire +4 more sources
GLP-1 Receptor Agonists Help Legs
Diabetes CareRonald M. Goldenberg, Subodh Verma
openaire +2 more sources